Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Meta-analysis
100%
Primary Prevention
100%
Randomized Trial
100%
Secondary Prevention
100%
Individual Participant Data
100%
Aspirin
100%
Vascular Disease
100%
Vascular Events
85%
Primary Prevention Trials
42%
Secondary Prevention Trials
42%
Risk Factors
28%
Hemorrhagic Stroke
28%
Bleeding
28%
Average Risk
28%
Major Bleed
28%
Medical Research Council
14%
Cancer Research
14%
Myocardial Infarction
14%
Gastrointestinal
14%
Absolute Reductions
14%
Intention-to-treat Analysis
14%
British Heart Foundation
14%
Treatment Duration
14%
Extracranial
14%
Nonfatal Myocardial Infarction
14%
Lower Average
14%
European Community
14%
Net Effect
14%
Net Benefit
14%
Coronary Events
14%
Peripheral Vascular Disease
14%
Coronary Disease
14%
Vascular Mortality
14%
Net Value
14%
Low-dose Aspirin
14%
Vascular Death
14%
Medicine and Dentistry
Primary Prevention
100%
Meta-Analysis
100%
Secondary Prevention
100%
Acetylsalicylic Acid
100%
Vascular Disease
100%
Apoplexy
50%
Ciclonicate
37%
Myocardial Infarction
25%
Cerebral Hemorrhage
25%
Medical Research
12%
Cancer Research
12%
Low Drug Dose
12%
Bleeding
12%
Intention-to-Treat Analysis
12%
Coronary Artery Disease
12%
Arteriosclerosis Obliterans
12%
Diseases
12%
Nursing and Health Professions
Primary Prevention
100%
Meta Analysis
100%
Secondary Prevention
100%
Vascular Disease
100%
Cerebrovascular Accident
66%
Ciclonicate
50%
Heart Infarction
33%
Brain Hemorrhage
33%
Low Drug Dose
16%
Coronary Artery Disease
16%
Intention to Treat Analysis
16%
Bleeding
16%
Cancer Research
16%
Peripheral Occlusive Artery Disease
16%
Diseases
16%